DY

David Yang

Investment Team at Lux Capital

San Francisco Bay Area

Overview 

David Yang is currently part of the Investment Team at Lux Capital, focusing on sectors such as Logistics, DeepTech, Digital Health, and AI. With previous roles at Latus Bio as Co-founder and Head of Ops & Strategy, as well as experience at 8VC and the Broad Institute of MIT and Harvard, David has a strong background in investment and biotech research.

Work Experience 

  • Director Board of Directors

    2025 - Current

  • Investment Team

    2024

    Early-stage life sciences investments & incubations Co-founding investor, Stealth NewCo

Lux Capital is an investment firm that invests in counter-conventional, seed-stage science and technology ventures.

  • Co-Founder

    2022

    0 → 1

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.

Raised $54,000,000.00 from The Children's Hospital of Philadelphia, Modi Ventures, 8VC, Gaingels, Samsung Life Science Fund, DCVC Bio and Ben Franklin Technology Partners.

  • Investment Team

    2020 - 2024

    Select portfolio: Photys Tx, Dren Bio, Latus Bio, Unlearn AI, Orchestra Bio, Portal Bio, Latent Labs

8VC transform the technology infrastructure behind many industries.

  • Board Observer

    2023 - 2024

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Raised $134,850,000.00 from Wittington Ventures, Radical Ventures, DCVC Bio, DCVC, 8VC, Insight Partners, EPIC Ventures, Mubadala Capital, Necessary Ventures and Altimeter Capital.

  • Board Observer

    2023 - 2024

  • Board Observer

    2023 - 2024

Atomic AI is a developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.

Raised $42,000,000.00 from Modi Ventures, Nat Friedman, Neal Khosla, Patrick David Hsu, Doug Mohr, Greylock, Factory, Not Boring, AME Cloud Ventures and Playground Global.

  • Board Observer

    2022 - 2024

Flywheel.io is a data management and analysis platform built specifically for scientists and the researcher's workflow.

Raised $105,289,919.00 from iSelect Fund, Novalis LifeSciences, Key Fund, Beringea, 8VC, Gundersen Health System, Seraph Group, Great North Ventures, Intuitive Ventures and Invenshure.

  • Board Observer

    2021 - 2024

  • Research Associate

    2017 - 2020

    Developed new methods for infectious disease diagnostics and surveillance. Associated publications: * HC Metsky et al. Nature Biotechnology (2022) * DS Griesemer et al. Cell (2021) * CM Ackerman and C Myhrvold et al. Nature (2020) * DK Yang et al. Machine Learning in Computational Biology (2019) * HC Metsky and KJ Siddle et al. Nature Biotechnology (2019) https://scholar.google.com/citations?user=09tlyHEAAAAJ&hl

Articles About David

Relevant Websites